Repligen
RGEN
#2564
Rank
$6.63 B
Marketcap
$117.82
Share price
5.68%
Change (1 day)
-7.40%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of December 2025 : $2.10 Billion USD

According to Repligen 's latest financial reports the company has $2.10 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$$2.10 B6.76%
2024-12-31$$1.97 B0.4%
2023-12-31$$1.96 B2.83%
2022-12-31$$1.91 B9.18%
2021-12-31$$1.75 B14.45%
2020-12-31$$1.52 B44.29%
2019-12-31$$1.05 B72.16%
2018-12-31$$0.61 B4.06%
2017-12-31$$0.59 B250.52%
2016-12-31$$0.16 B37.49%
2015-12-31$$0.12 B9.86%
2014-12-31$$0.11 B7.55%
2013-12-31$$0.10 B23.49%
2012-12-31$$84.12 M
2011-03-31$$67.08 M1.46%
2010-03-31$$66.12 M-4.34%
2009-03-31$$69.12 M7.83%
2008-03-31$$64.1 M151.02%
2007-03-31$$25.53 M0.41%
2006-03-31$$25.43 M4.71%
2005-03-31$$24.28 M-10.58%
2004-03-31$$27.16 M10.65%
2003-03-31$$24.54 M-7.17%
2002-03-31$$26.44 M-14.39%
2001-03-31$$30.89 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$86.77 B 4,020.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$53.53 B 2,441.91%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$18.89 B 797.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.50 B 778.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$6.24 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$0.13 Billion-106.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$3.25 B 54.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$2.01 B-4.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.08 B 189.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$3.21 B 52.47%๐Ÿ‡บ๐Ÿ‡ธ USA